CD274 and cancer: Immune checkpoint inhibitors (ICIs) are novel drugs targeting programmed cell death protein 1-ligand 1 (PD-L1, synonym CD274, B7 homolog 1) or its receptor (PD-1, synonym CD 279), and are increasingly used in cancer therapy (1).